Table 2. Risk of aggressive prostate cancer (Gleason score ≥ 7) by PSA variation over time (after Boniol et al, 2015).
PSA variation | Subjects | Prostate cancers | Gleason score ≥ 7 | OR* | 95%CI | |
---|---|---|---|---|---|---|
Lower bound | Upper bound | |||||
< -50% | 872 | 25 | 16 | 0.75 | 0.33 | 1.71 |
-50%; -20% | 5199 | 263 | 149 | 1.01 | 0.77 | 1.32 |
-20%; +20% | 15723 | 1424 | 806 | 1.00 | Reference | |
+20%; +50% | 5697 | 659 | 371 | 0.98 | 0.82 | 1.19 |
> +50% | 3766 | 381 | 214 | 0.95 | 0.75 | 1.19 |
Model adjusted for age and baseline PSA value.